Inclusion Criteria:

• * Clinical diagnosis of cirrhosis based on histology and/or imaging specified in the protocol.
• * Evidence of portal hypertension - must meet at least one of the following criteria:
• * Ascites (present or within past 2 years)
• * Varices (seen by Esophagogastroduodenoscopy or by Ultrasound(US) or cross-sectional imaging)
• * Fibroscan Liver stiffness measurement (LSM) \>25 kilopascals (kPa) (if no other factors present)
• * Magnetic resonance elastography (MRE) LSM \> 5 kPa (if no other factors present)
• * Acoustic radiation force impulse LSM \> 17kpa (if no other factors present)
• * Hepatic vein pressure gradient \> 10 millimetres of mercury (mmHg)
• * Portal hypertensive gastropathy seen on Esophagogastroduodenoscopy
• * Platelet count \< 80/ units per liter (uL)
• * Recanalized umbilical vein (by US or cross-sectional imaging)
• * Access to Wireless Fidelity (Wi-Fi) at home
• * Owns or access to a smartphone, tablet or computer
• * English or Spanish speaking
• * Willing to participate in exercise program

Exclusion Criteria:

• * Overt hepatic encephalopathy (HE) within 6 months, requiring \>28 days total of lactulose
• * Took lactulose for non - HE reasons for \>28 days total in last 6 months
• * Took Rifaximin for \> 28 days total in last 6 months
• * Model for End Stage Liver Disease (MELD) \> 25 (Exception: MELD \> 25 with clinically stable End-Stage Renal Disease (ESRD) for whom the bilirubin is \< 5 g/dL)
• * Barcelona Clinic Liver Cancer (BCLC) \> C Hepatocellular Carcinoma (HCC)
• * Currently taking Sorafenib, Atezolizumab/Bevacizumab, Regorafinib, or Cabozatinib
• * Greater than (\>) 3 paracentesis/month in last 2 months
• * Active Metastatic solid malignancy or acute leukemia within last 3 years
• * Severe cognitive, vision, or hearing impairment (without use of corrective lenses or hearing assist devices) or psychiatric illness precluding study participation
• * Currently participates in Tai-Chi or performs \>150 min/week vigorous physical activity
• * Currently receiving lower body physical and/or occupational therapy
• * Living in an assisted living facility
• * Hemoglobin A1C \> 12 (within past 12 months)
• * Requires a low galactose diet
• * Deemed unsuitable by the study investigator
• Inclusion Criteria for the Caregivers of the participants:
• * Adult \> 18 years of age
• * Informal caregiver of a participant enrolled in LIVE-SMART
• * English speaking
• Exclusion Criteria for the Caregivers of the participants:
• - Non-English speaking